Evaluation of a Bile Acid Antibiotic That Can Treat Superbug Bacterial Infection

AJAS · 2026 Microbiology (inferred)

Overview

Antibiotics have revolutionized medicine, saving countless lives since the introduction of penicillin. However, antimicrobial resistance has challenged their efficacy, prompting ongoing efforts to develop new antibiotics. This study aimed to explore the antimicrobial effects of a bile acid derivative, BA-3/4-Butyl, by analyzing its interactions and mechanism of action against bacteria using a variety of assays. It is revealed that BA-3/4-Butyl exerts its antimicrobial activity via membrane permeabilization and that an efflux pump inhibitor and pharmacokinetic constraint exists. The zones of inhibition increased with BA-¾-Butyl concentration. A one-way ANOVA with a significance level (alpha) set at 0.05 gave a p-value of <0.01. These findings provide insights into how BA-3/4-Butyl compromises bacterial membranes without causing toxicity in its mammalian counterparts. This study advances understanding of BA-3/4-Butyl’s antimicrobial activity and potential mechanisms of action, ultimately aiding the development of similar novel therapeutic agents to help combat antimicrobial resistance.

Competition history

  • AJAS 2026 Category not listed

Related projects

Closest projects by meaning, across every fair and year in the corpus.

Browse more like this

Source: AAAS Annual Meeting (Confex) / American Junior Academy of Science

Save projects to your library

Sign in with Google to keep track of projects you find interesting, organized into folders. An account also raises your daily allowance for “Has this been done?”, and lets you create a key for the MCP server with a much higher limit than anonymous use. Browsing stays public.

Continue with Google